A new development has been a drag on its share price, but Ventum Capital Markets analyst Stefan Quen... Read More
Its Q4 results are in the books and Raymond James analyst Rahul Sarugaser still thinks there is a li... Read More
Following a new development, Echelon Capital Markets analyst Stefan Quenneville has raised his price... Read More
A new development at Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Chart, News, Anal... Read More
After a disappointing quarter, Echelon Capital Markets analyst Stefan Quenneville has lowered his pr... Read More
Following moves by the company to shore up its balance sheet, Research Capital analyst Andre Uddin i... Read More
Following a finance move from the company, Raymond James analyst Rahul Sarugaser believes there is a... Read More
It’s been a wild ride for Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Charts, Ne... Read More
Echelon Capital Markets analyst Stefan Quenneville stayed bullish on Medexus Pharmaceuticals (Medexu... Read More
After reviewing the latest quarterly results from Medexus Pharmaceuticals (Medexus Pharmaceuticals S... Read More
Strong quarterly revenue looks good on Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote,... Read More
Calling it a compelling opportunity for investors, Echelon Capital Markets analyst Stefan Quennevill... Read More
There’s a favourable risk-reward opportunity to Canadian specialty pharma name Medexus Pharmaceuti... Read More
Biotech, more than any other sector, is a game of longshots. Most great investors in the space own a... Read More
Québec-based specialty pharma company Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote,... Read More
Research Capital Corporation analyst Andre Uddin says specialty pharma company Medexus Pharmaceutica... Read More
Raymond James analyst Rahul Sarugaser reiterated an “Outperform” rating on Québec-based special... Read More
Shares of specialty pharma name Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Charts... Read More